The RelA NF-κB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells

NF-κB/Rel transcription factors regulate many genes involved in control of cellular proliferation, neoplastic transformation, and apoptosis, including the c-myc oncogene. Recently, we have observed that levels of NF-κB and aryl hydrocarbon receptor (AhR), which mediates malignant transformation by environmental carcinogens, are highly elevated and appear constitutively active in breast cancer cells. Rel factors have been found to functionally interact with other transcription factors. Here we demonstrate a physical and functional association between the RelA subunit of NF-κB and AhR resulting in the activation of c-myc gene transcription in breast cancer cells. RelA and AhR proteins were co-immunoprecipitated from cytoplasmic and nuclear extracts of non-malignant MCF-10F breast epithelial and malignant Hs578T breast cancer cells. In transient co-transfection, RelA and AhR gene products demonstrated cooperation in transactivation of the c-myc promoter, which was dependent on the NF-κB elements, and in induction of endogenous c-Myc protein levels. A novel AhR/RelA-containing NF-κB element binding complex was identified by electrophoretic mobility shift analysis of nuclear extracts from RelA and AhR co-transfected Hs578T cells. Thus, the RelA and AhR proteins functionally cooperate to bind to NF-κB elements and induce c-myc gene expression. These findings suggest a novel signaling mechanism whereby the Ah receptor can stimulate proliferation and tumorigenesis of mammary cells.

[1]  F. Matsumura,et al.  Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. , 1996, Biochemical pharmacology.

[2]  G. Sonenshein,et al.  Nuclear factor kappaB cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[3]  E. Kalkhoven,et al.  Distinct Domains of the RelA NF-κB Subunit Are Required for Negative Cross-talk and Direct Interaction with the Glucocorticoid Receptor* , 1997, The Journal of Biological Chemistry.

[4]  T. Pineau,et al.  Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor , 1995, Science.

[5]  G. Sonenshein,et al.  Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Perdew,et al.  Characterization of the activated form of the aryl hydrocarbon receptor in the nucleus of HeLa cells in the absence of exogenous ligand. , 1996, Archives of biochemistry and biophysics.

[7]  C. Bradfield,et al.  Characterization of the Ah Receptor-associated Protein, ARA9* , 1998, The Journal of Biological Chemistry.

[8]  M. Gallo,et al.  Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity* , 1999, The Journal of Biological Chemistry.

[9]  J. Whitlock,et al.  The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin , 1996, Molecular and cellular biology.

[10]  R. Pollenz,et al.  The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. , 1994, Molecular pharmacology.

[11]  K. Khalili,et al.  Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1 , 1996, Journal of virology.

[12]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[13]  E. Kalkhoven,et al.  Negative Interaction between the RelA(p65) Subunit of NF-B and the Progesterone Receptor (*) , 1996, The Journal of Biological Chemistry.

[14]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[15]  G. Held,et al.  Adverse reproductive outcomes in the transgenic Ah receptor-deficient mouse. , 1999, Toxicology and applied pharmacology.

[16]  D. Nebert,et al.  Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. , 1991, Pharmacogenetics.

[17]  C. Elferink,et al.  A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma Protein , 1998, The Journal of Biological Chemistry.

[18]  G. Sonenshein,et al.  NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts , 1992, The Journal of experimental medicine.

[19]  A. Fornace,et al.  Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm. , 1990, Environmental health perspectives.

[20]  A. Bassuk,et al.  Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells , 1997, Journal of virology.

[21]  J. Trauger,et al.  Inhibition of Ets-1 DNA Binding and Ternary Complex Formation between Ets-1, NF-κB, and DNA by a Designed DNA-binding Ligand* , 1999, The Journal of Biological Chemistry.

[22]  F. A. La Rosa,et al.  Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors , 1994, Molecular and cellular biology.

[23]  H. Swanson,et al.  In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Russo,et al.  Transformation of human breast epithelial cells by chemical carcinogens. , 1993, Carcinogenesis.

[25]  B. Jhun,et al.  Bcl3, an IκB Protein, Stimulates Activating Protein-1 Transactivation and Cellular Proliferation* , 1999, The Journal of Biological Chemistry.

[26]  B. Kahn-Perlès,et al.  Physical interaction of the bHLH LYL1 protein and NF-κB1 p105 , 1999, Oncogene.

[27]  A. Puga,et al.  Constitutive Activation of the Aromatic Hydrocarbon Receptor , 1998, Molecular and Cellular Biology.

[28]  P. Harper,et al.  The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. , 1994, Toxicology letters.

[29]  G. Perdew,et al.  Mapping the 90 kDa heat shock protein binding region of the Ah receptor , 1996, Biochemistry and molecular biology international.

[30]  E M Schwarz,et al.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.

[31]  P. Baeuerle,et al.  The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. , 1993, The Biochemical journal.

[32]  J. V. Vanden Heuvel,et al.  Hepatitis B Virus X-Associated Protein 2 Is a Subunit of the Unliganded Aryl Hydrocarbon Receptor Core Complex and Exhibits Transcriptional Enhancer Activity , 1998, Molecular and Cellular Biology.

[33]  E. L. Springer,et al.  Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. , 1977, Journal of the National Cancer Institute.

[34]  W. Greene,et al.  The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Stavnezer,et al.  Interaction of Stat6 and NF-κB: Direct Association and Synergistic Activation of Interleukin-4-Induced Transcription , 1998, Molecular and Cellular Biology.

[36]  A. Baldwin,et al.  Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. , 1993, Molecular and cellular biology.

[37]  A. E. Rogers,et al.  Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.

[38]  P. Toselli,et al.  Induction of PreB cell apoptosis by 7,12-dimethylbenz[a]anthracene in long-term primary murine bone marrow cultures. , 1997, Toxicology and applied pharmacology.

[39]  Garet P Lahvis,et al.  Ahr null alleles: distinctive or different? , 1998, Biochemical pharmacology.

[40]  H. Preisler,et al.  Evaluation of c-myc proto-oncogene in primary human breast carcinomas. , 1991, Anticancer research.

[41]  C. Bradfield,et al.  Ligand-dependent Interaction of the Aryl Hydrocarbon Receptor with a Novel Immunophilin Homolog in Vivo* , 1997, The Journal of Biological Chemistry.

[42]  F. A. La Rosa,et al.  A novel NF-kappa B element within exon 1 of the murine c-myc gene. , 1992, Oncogene.

[43]  J. Williams,et al.  Characterization of 2,3,7,8-tetrachlorodibenzofuran-dependent suppression and AH receptor pathway gene expression in the developing mouse mammary gland. , 1998, Toxicology and applied pharmacology.

[44]  M. Fernö,et al.  c‐myc amplification is an independent prognostic factor in postmenopausal breast cancer , 1992, International journal of cancer.

[45]  J. Tilly,et al.  The aryl hydrocarbon receptor, a basic helix-loop-helix transcription factor of the PAS gene family, is required for normal ovarian germ cell dynamics in the mouse. , 2000, Endocrinology.